ARK Investment Management - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q4 2022$151
-100.0%
17
-100.0%
0.00%
-100.0%
Q3 2022$1,778,000
-38.4%
145,292
-42.6%
0.01%
-29.4%
Q2 2022$2,885,000
-81.0%
253,326
-68.2%
0.02%
-73.0%
Q1 2022$15,164,000
-86.5%
797,241
-81.1%
0.06%
-81.4%
Q4 2021$111,996,000
-56.7%
4,218,302
-33.0%
0.34%
-45.4%
Q3 2021$258,696,000
-36.4%
6,297,359
-12.3%
0.62%
-18.0%
Q2 2021$406,678,000
+10.6%
7,180,055
-18.0%
0.76%
+3.7%
Q1 2021$367,581,000
-48.2%
8,751,923
-13.6%
0.73%
-61.4%
Q4 2020$709,903,000
+137.1%
10,125,564
-5.1%
1.89%
+6.4%
Q3 2020$299,412,000
+34.1%
10,670,424
+41.4%
1.78%
-26.0%
Q2 2020$223,215,000
+111.0%
7,546,146
+41.4%
2.40%
-8.9%
Q1 2020$105,812,000
-19.6%
5,335,941
+20.0%
2.64%
-20.6%
Q4 2019$131,684,000
+17.4%
4,447,277
-9.8%
3.32%
+35.7%
Q3 2019$112,163,000
-6.5%
4,932,398
+1.7%
2.45%
-19.0%
Q2 2019$119,943,000
+7.6%
4,848,148
+6.3%
3.02%
-5.1%
Q1 2019$111,478,000
+62.0%
4,559,434
+50.8%
3.18%
+14.0%
Q4 2018$68,807,000
-22.6%
3,024,489
+8.3%
2.79%
+4.0%
Q3 2018$88,900,000
+13.7%
2,793,854
+28.1%
2.69%
-6.2%
Q2 2018$78,166,000
+45.5%
2,181,572
+34.6%
2.86%
+7.4%
Q1 2018$53,710,000
+57.1%
1,620,208
+45.6%
2.67%
-2.1%
Q4 2017$34,198,000
+299.5%
1,112,845
+118.1%
2.72%
+63.4%
Q2 2017$8,561,000
+66.8%
510,187
+121.9%
1.67%
+12.7%
Q1 2017$5,132,000229,9221.48%
Other shareholders
EDITAS MEDICINE INC shareholders Q2 2022
NameSharesValueWeighting ↓
PFM Health Sciences, LP 1,466,732$13,009,9130.47%
Green Alpha Advisors, LLC 59,655$529,0000.44%
Edgestream Partners, L.P. 298,901$2,651,2520.30%
Woodline Partners LP 2,078,748$18,438,4950.25%
Spectrum Planning & Advisory Services Inc. 14,775$131,0540.18%
Lombard Odier Asset Management (Switzerland) SA 242,248$2,148,7400.17%
PDT Partners, LLC 109,600$972,1520.16%
AXQ CAPITAL, LP 20,801$184,5050.13%
SHELTON CAPITAL MANAGEMENT 135,200$1,199,2240.13%
NIA IMPACT ADVISORS, LLC 13,931$123,5680.07%
View complete list of EDITAS MEDICINE INC shareholders